Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sunscreen Group Suggests User Fees To Expedite Ingredient Reviews

This article was originally published in The Tan Sheet

Executive Summary

The Public Access to SunScreens Coalition will recommend a user fee program to improve FDA’s work on TEAs for OTC ingredients. “Despite a number of OTC applications waiting for approval for several years, FDA has not completed the review of applications for any new sunscreen components,” PASS says.

Advertisement

Related Content

FDA Proposal For Increased Sunscreen Safety Testing On NDAC Agenda
Most U.S. Sunscreens Not So Hot, Reflecting FDA Failures – EWG
FDA Acting Rx-to-OTC Switch Review Leader Prioritizes Personnel
Guidance Underscores FDA Practice Of Letting TEAs Steep
FDA Strengthens Sunscreen Testing And Label Requirements
Sanofi-Aventis offer

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS106281

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel